Menu Search
Equities

ImExHS Ltd

IME:ASX

ImExHS Ltd

Actions
Health CareHealth Care Providers
  • Price (AUD)0.4175
  • Today's Change0.00 / 0.00%
  • Shares traded9.36k
  • 1 Year change-33.73%
  • Beta1.1680
Data delayed at least 20 minutes, as of Nov 13 2024 04:12 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year ImExHS Ltd had net income fall 37.97% from a loss of 3.04m to a larger loss of 4.19m despite a 14.79% increase in revenues from 17.16m to 19.70m.
Gross margin31.95%
Net profit margin-13.85%
Operating margin-11.77%
Return on assets-15.28%
Return on equity-21.50%
Return on investment-20.83%
More ▼

Cash flow in AUDView more

In 2023, ImExHS Ltd increased its cash reserves by 23.53%, or 449.90k. The company earned 2.61m from its operations for a Cash Flow Margin of 13.25%. In addition the company used 2.13m on investing activities and also paid 98.61k in financing cash flows.
Cash flow per share-0.0206
Price/Cash flow per share--
Book value per share0.3314
Tangible book value per share0.1526
More ▼

Balance sheet in AUDView more

ImExHS Ltd has a Debt to Total Capital ratio of 5.93%, a higher figure than the previous year's 3.45%.
Current ratio1.57
Quick ratio1.53
Total debt/total equity0.063
Total debt/total capital0.0593
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.